Agenda.
- Draft Agenda -
Thursday 16th April 2026
0845 - 0900
Welcome Address:
Prof Richard Power, Beaumont Hospital, Dublin
Chairs: Ms Catherine Dowling, University Hospital Galway & Dr Wassim Darwish, Mater Misericordiae University
Hospital, Dublin
0900 – 0920
Dr Alastair Lamb, St Bart’s Cancer Institute, London
State of the Art in Prostate Biopsy - Is There a Best Way To Do It?
0920 – 0940
Dr Max Kates, Johns Hopkins,
BCG Naive & Unresponsive NMIBC: What We Can Learn From Recent Trials
0940 – 1000
Dr Maria Jiang, Princess Margaret Cancer Centre, Toronto
Theranostics in Prostate Cancer - From Research to Practice
1000 – 1020
Dr Alejandro Berlin, Princess Margaret, Cancer Centre, Toronto
SBRT for Oligometastatic Prostate Cancer: Local Therapy in a Systemic Disease?
1020 – 1040
Ms Rebecca Martin, The Royal
Living With & Beyond Cystectomy in Bladder Cancer
1040 – 1110
Coffee Break
Chairs:
Dr Nick Mayer, Cork University Hospital & Mr Paul Sweeney, Mercy University Hospital, Cork
1110 – 1120
Prof Ray McDermott, St Vincent’s University Hospital
Update on The National Centre for Testis Cancer Surgery
1120 – 1140
Prof Daniel Berney, Bart’s Cancer Institute, London
Testis Pathology
1140 – 1200
Dr Rachel Glicksman, University of Toronto
Is There a Role for Radiotherapy in Seminoma?
1200 - 1300
Lunch
Chairs:
Dr Nick Mayer, Cork University Hospital & Mr Paul Sweeney, Mercy University Hospital, Cork
1300 – 1320
Dr Darren Feldman, MSKCC, New York
State of the Art Management of GCT: Principles & Pitfalls
1320 – 1340
Dr Richard Matulewicz, MSKCC, New York
Evolution in the Surgical Approach to Metastatic GCTs
1340 - 1400
Ms Maryann Carousso, MSKCC, New York
Assessing Metabolic Syndrome in Patients Treated with Chemotherapy for GCT
1415 – 1500
Testis Panel Discussion
Chair:
Prof John McCaffrey, Mater Misericordiae University Hospital, Dublin
Panelists:
Prof Ray McDermott, St Vincent’s University Hospital, Dublin
Prof Daniel Berney, Bart’s Cancer Institute, London
Dr Rachel Glicksman, University of Toronto
Dr Darren Feldman, MSKCC, New York
Dr Richard Matulewicz, MSKCC, New York
Ms Maryann Carousso, MSKCC, New York
Dr Lynda Corrigan, Tallaght University Hospital, Dublin
1445 - 1515
Coffee Break
Chairs:
Ms Anna Walsh, Beacon Hospital, Dublin & Dr Richard Moore, Mater Private Hospital, Dublin
1515 – 1535
Prof Greg Shaw, University College Hospital, London
Improving Potency After Radical Prostatectomy - Neurosafe & Beyond
1535 – 1555
Dr Gopakumar Iyer, MSKCC, New York
Advancements in the Management of Muscle-Invasive & Metastatic Urothelial Cancer
1555 – 1615
Prof Suneil Jain, Queen’s University, Belfast.
Prostate SABR
1615 – 1635
Ms Amy O’Connor, Movember Foundation
The Real Face of Men’s Health in Ireland
1635 – 1715
Bladder Panel Discussion
Chair:
Ms Nikita Bhatt, St Vincent’s University Hospital, Dublin
Panelists:
Dr Max Kates, Johns Hopkins, Baltimore
Dr Alejandro Berlin, Princess Margaret Cancer Centre, Toronto
Dr Gopakumar Iyer, MSKCC, New York
Dr Richard O’Dwyer, Mater Misericordiae University Hospital, Dublin
Prof Niall Swan, St Vincent’s University Hospital, Dublin
Dr Niamh Peters, University Hospital Limerick
Friday 17th April 2026
Welcome Back:
Mr Gregory Nason, Mater Misericordiae University Hospital, Dublin
Chairs:
Ms Louise McLoughlin, St James' Hospital, Dublin & Dr Patricia Daly, St James’s Hospital, Dublin
0840 – 0900
Prof Derya Tilki, University Medical Centre Hamburg
Biochemical Recurrence & Persistent PSA After Radical Prostatectomy
0900 – 0920
Dr Alejandro Berlin, Princess Margaret Cancer Centre, Toronto
Saving the Bladder Without Compromising Cure: Organ-Sparing Oncology Done Right
0920 – 0940
Dr Maria Jiang, Princess Margaret Cancer Centre, Toronto
Emerging Therapeutic Strategies for Prostate Cancer
0940 – 1000
Dr Max Kates, Johns Hopkins, Baltimore
The Role of Radical Cystectomy in 2026 vs 2036
1000 – 1020
Dr Darren Feldman, MSKCC, New York
Landscape of New Trials & Targets in Relapsed/Refractory Germ Cell Tumors
1020 - 1100
Coffee Break
Chairs:
Ms Beth Hickerton, Cork University Hospital & Dr Niamh Peters, University Hospital Limerick
1100 – 1120
Dr Alastair Lamb, Bart’s Cancer Institute, London
Next Generation Risk Stratification: How to Solve the Prostate Cancer Conundrum
1120 – 1140
Prof Suneil Jain, Queen’s University, Belfast
Peri-Rectal Spacers in Prostate Cancer
1140 – 1200
Prof Greg Shaw, University College Hospital, London
Does Length Matter? Continence Recovery After Prostate Surgery
1200 – 1220
Prof Derya Tilki, University Medical Centre Hamburg
EAU 2026 Guidelines update: Localized Prostate Cancer
1220- 1320
Prostate Panel Discussion
Chair:
Mr David Galvin, Mater Misericordiae University Hospital, Dublin
Panelists:
Dr Alastair Lamb, Bart’s Cancer Institute, London
Prof Greg Shaw, University College Hospital, London
Prof Derya Tilki, University Medical Centre Hamburg
Prof Suneil Jain, Queen’s University, Belfast
Prof Daniel Berney, Bart’s Cancer Institute, London
1320
Meeting Close & Lunch
Download PDF Agenda